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Abstract
Background: Streptococcus agalactiae (Group B Streptococcus; GBS) is a major contributor to obstetric and neonatal
bacterial sepsis. Serotype III strains cause the majority of late-onset sepsis and meningitis in babies, and thus appear to
have an enhanced invasive capacity compared with the other serotypes that cause disease predominantly in
immunocompromised pregnant women. We compared the serotype III and V whole genome sequences, strains NEM316
and 2603VR respectively, in an attempt to identify genetic attributes of strain NEM316 that might explain the propensity
of strain NEM316 to cause late-onset disease in babies. Fourteen putative pathogenicity islands were described in the
strain NEM316 whole genome sequence. Using PCR- and targeted microarray- strategies, the presence of these islands
were assessed in a diverse strain collection including 18 colonizing isolates from healthy pregnant women, and 13 and 8
invasive isolates from infants with early- and late-onset sepsis, respectively.
Results: Side-by-side comparison of the strain NEM316 and strain 2603VR genomes revealed that they are extremely
similar, with the only major difference being the capsulation loci and mobile genetic elements. PCR and Comparative
Genome Hybridization (CGH) were used to define the presence of each island in 39 GBS isolates. Only islands I, VI, XII,
and possibly X, met criteria of a true pathogenicity island, but no significant correlation was found between the presence
of any of the fourteen islands and whether the strains were invasive or colonizing. Possible associations were seen
between the presence of island VI and late-onset sepsis, and island X and early-onset sepsis, which warrant further
investigation.
Conclusion: The NEM316 and 2603VR strains are remarkable in that their whole genome sequences are so similar,
suggesting that the capsulation loci or other genetic differences, such as pathogenicity islands, are the main determinants
of the propensity of serotype III strains to cause late-onset disease. This study supports the notion that GBS strain
NEM316 has four putative pathogenicity islands, but none is absolutely necessary for disease causation, whether early-
or late-onset sepsis. Mobile genetic elements are a common feature of GBS isolates, with each strain having its own
peculiar burden of transposons, phages, integrases and integrated plasmids. The majority of these are unlikely to influence
the disease capacity of an isolate. Serotype associated disease phenotypes may thus be solely related to differences in the
capsulation loci.
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Streptococcus agalactiae (Group B Streptococcus, GBS) is a
Gram positive, facultative anaerobic bacterium that is the
most common cause of neonatal and obstetric sepsis, and
is an increasingly important cause of septicaemia in eld-
erly and immunocompromised patients [1]. Serotype III
GBS causes approximately 37% of early-onset and 67% of
late-onset neonatal GBS sepsis (compared with 13% and
5%, respectively, caused by serotype V), and is the pre-
dominant serotype causing late-onset meningitis [1,2].
Serotype V prevails in invasive infection in non-pregnant
adults (causing 29% of all such infections) [3]. The
genetic determinants of the propensity of serotype III GBS
to cause late-onset sepsis and meningitis have not been
fully elucidated, but the availability of whole genome
sequences of a serotype III isolate (strain NEM316) and a
serotype V isolate (strain 2306VR) brings this prospect
closer [4,5]. One possibility is that the serotype III GBS
has pathogenicity islands (PAIs) that are not present in the
other serotypes, and which confer an enhanced invasive
potential. Glaser et al. [4] described fourteen regions of
strain NEM316 that they considered to be putative PAIs.
These islands are composed of 11 to 77 genes and contain
most of the mobile elements in the NEM316 genome [4].
Six of the islands are adjacent to tRNA genes, a feature of
pathogenicity islands [6], and many known or putative
virulence genes of GBS are contained within these regions.
For instance, alp2 [7] is in 'island IV', the cyl operon [8] is
in 'island VI', and lmb and scpB are in 'island XII' [9]. PAIs
are defined by the following criteria: (1) they carry one or
more virulence genes, (2) they are present in the genome
of pathogenic bacterium but absent in non-pathogenic
representatives of the same species, (3) they are frequently
located adjacent to tRNA genes, (4) they are associated
with mobile genetic elements and are often flanked by
direct repeats (DR), (5) they are unstable and either the
whole of the PAI or part of it may be deleted, and (6) often
represent mosaic like structures rather than homogenous
segments of horizontally acquired DNA [10].
We used the C. elegans database genome sequence graph-
ical interface (AceDB) [11,12] to compare the strain
NEM316 and the strain 2603VR genome sequences to
identify serotype III and V genomic differences, and to fur-
ther define the putative PAIs in the NEM316 serotype III
strain. We then conducted PCR amplification and targeted
microarray-based comparative genome hybridization
(CGH) studies aimed at delineating the nature of the
putative PAIs.
Results
NCBI and AceDB analysis of the sequenced serotype III 
and V genomes
Side-by-side comparison of the serotype III and V genome
sequences, strains NEM316 and 2603VR respectively,
identified numerous annotation differences between
open reading frames, most generated by true or sequenc-
ing error frame shifts and differences in the annotation of
initiation codons. The similarity of the two genomes is
otherwise remarkable (see figure 1). The other major dif-
ferences between the two genomes are the capsulation loci
and the presence of multiple mobile elements including
integrated plasmids, prophages, transposons, and one to
two gene integrases/transposases. Much of this acquired
DNA appears to be unique to each sequenced strain (rep-
resented by triangles in figure 1), in the type of mobile ele-
ment but not necessarily the genomic location.
Which islands appear to be real PAIs?
PAIs contain virulence and mobilization genes and are
flanked by direct repeat (DR) sequences that are recog-
nised by mobilization proteins [10]. Potential PAIs must
be distinguished from non-mobile regions of the chromo-
some that contain virulence genes adjacent to tRNA genes,
and which have merely attracted mobile elements. Such
mobile elements may themselves be genomic or meta-
bolic islands but by definition they are not PAIs, unless
they mobilize virulence genes and are associated with
pathogenic strains [10].
Our annotation of the putative PAIs is given in table 1.
The putative PAIs are present in both strain NEM316 and
strain 2603VR, with the exception of islands III, VII, VIII
and X, which are only present in strain NEM316. Islands
III, VII, and VIII were described as identical copies of a
chromosomally integrated plasmid, designated
pNEM316-1. Two further islands are present in strain
2603VR that are not present in strain NEM316: sag0915-
0937 (a copy of Tn916) and sag1835-1886 (a prophage).
None of these mobile elements contain known virulence
genes, and they may therefore not be true PAIs.
Inserted into the ends of islands II, IV, V, XI, XIII and XIV,
and the middle of island VI, are mobile elements that con-
tain phage or transposon genes, but no known virulence
genes (see table 1). The mobile elements in strain
NEM316 are different from those in strain 2603VR at each
of these sites of insertion. The putative PAIs do not other-
wise contain mobilization genes or flanking DR
sequences. Island IX contains a two-component regulator,
but has no mobilization genes. These putative PAIs may
therefore merely represent non-mobile regions of the
genome into which phages and transposons have
inserted.
Islands I, VI and XII contain virulence genes (rgg[4,13,14],
the cyl locus, and lmb/scpB[9], respectively) flanked by
mobilization genes that are present in both sequenced
strains. Island X contains mobilization genes and is pre-
sumed to be mobile because it is only found in strainPage 2 of 13
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BMC Microbiology 2005, 5:31 http://www.biomedcentral.com/1471-2180/5/31NEM316 and not strain 2603VR. It also contains genes
encoding surface proteins that have an LPXTG signal
sequence; these could potentially have a virulence role.
Four regions of the GBS genome (islands I, VI, X and XII)
may therefore be real PAIs.
Other genomic differences
Aside from annotation discrepancies, mobile elements
and the capsulation loci, there are few other differences
between the two sequenced genomes. There is a possible
lone example of a Minimal Mobile Element (MME) [15].
Two genes present between purK and purB (genes involved
in purine metabolism) in strain NEM316 (gbs0045-0046)
compared with a single different gene in the same location
in strain 2603VR (sag0046). The putative MME was PCR
amplified in each of the 39 strains in our collection. Only
two insert types were amplified, of 2,036 bp and 1,636 bp.
Representatives of these were sequenced and found to
have the exact sequence of either gbs0045-0046 or
sag0046, respectively. All strains had either one or other
A representation of the serotype III (NEM316; gbs001-2136) and serotype V (2603VR; sag001-2175) genomes (diagrammatic and not to scale)Figure 1
A representation of the serotype III (NEM316; gbs001-2136) and serotype V (2603VR; sag001-2175) genomes 
(diagrammatic and not to scale). The genome sequences are mostly identical (represented by a horizontal line), triangles 
above the line represent gene regions unique to NEM316, and the triangles below are those present only in 2603VR. Boxed 
regions are putative PAIs (marked I to XIV). Grey bars with the PAIs represent genes amplified as surrogate markers for the 
presence of the whole island. Similar information can now be visualised through GenePlot, the NCBI pairwise comparison of 
protein homologs http://www.ncbi.nlm.nih.gov/sutils/geneplot.cgi.
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Putative PAI Position No. of genes Characteristics
I gbs0211-0235 25 Island I is adjacent to tRNA-Ala, begins with a phage integrase family site-specific 
recombinase (gbs0211) and a Cro/CI transcriptional regulator (gbs0212), and harbors 
other mobilization genes. The region contains rgg (gbs0230), a homologue of a virulence 
regulator in S. pyogenes.
II gbs0236-0254 19 Inserted into the proximal end of island II, adjacent to tRNA-Leu, are 9 genes in strain 
NEM316 (gbs0236-0244) not present in strain 2603VR, and 7 genes in strain 2603VR 
(sag0245-0251) not present in strain NEM316. Gbs0236-0244 consists of genes encoding 
a phage integrase and other phage proteins. Sag0245-0251 consists of genes encoding 
hypothetical proteins and a Cro/CI family regulator. Neither of these two regions harbor 
known virulence genes. In the remainder of island II (gbs0245-0254 or sag0252-0264), 
there are no other mobilization genes or known virulence genes.
III, VII, VIII gbs0361-0410
gbs0692-0740
gbs0969-1016
50
49
48
Islands III, VII, VIII are near-identical copies of a chromosomally integrated plasmid, 
designated pNEM316-1.
IV gbs0458-0482 
(gbs0458-0486*)
25 (29)* Gbs0458-0470 (or sag0423-0433) contains several transcriptional regulators, including 
araC family members, and the virulence factor alp, but does not harbor any identifiable 
mobilization genes. Inserted into the distal end of island IV, adjacent to tRNA-Thr, are 16 
genes in strain NEM316 (gbs0471-0486) not present in strain 2603VR, and 6 genes in 
strain 2603VR (sag0434-0439) not present in strain NEM316. Gbs0471-0486 contains an 
integrase (gbs0482) and a Cro/CI transcriptional regulator (gbs0475). Sag0434-0439 
contains an IS256 family transposase (sag0434), a phage family site-specific recombinase 
(sag0438). Neither of these elements contain known virulence genes.
V gbs0588-0598 11 Inserted into the proximal end of island V, adjacent to tRNA-Arg, is a single gene in strain 
NEM316 (gbs0588; an integrase) that is not present in strain 2603VR, and 65 genes in 
strain 2603VR (sag0545-0609) that are not present in strain NEM316. Sag0545-0609 
contains numerous prophage lambda genes. The remainder of island V (gbs0589-0598 or 
sag0610-0617) harbors genes encoding a cell membrane protein complex and a two-
component regulator, vncSR, flanked by two transposase genes (for instance, sag0611 a 
degenerate transposase and sag0618 a truncated transposase). There are no genes known 
to be involved in virulence in island V.
VI gbs0616-0678 63 Island VI contains the cyl locus (gbs0644-0655; sag0662-0673), encoding a β-hemolysin 
that has been shown unequivocally to be involved in virulence. The region preceding the 
cyl locus (gbs0616-0639) in strain NEM316 contains Tn5252 transposon genes, and is 
identical in strain 2603VR (sag0636-0657). Downstream of the cyl locus, in strain 
NEM316, there are neither mobilization genes nor other known virulence genes. In the 
middle of the island, three genes in strain NEM316 (gbs0656-0658; encoding a permease 
and hypothetical proteins) are not present in strain 2603VR, and 10 genes in strain 
2603VR (sag0674-0683; protease, endopeptidase and permease genes) are not present in 
strain NEM316. The distal half of island VI contains genes encoding core metabolic 
enzymes, and does not contain mobile elements or virulence determinants.
IX gbs1049-1076 28 Island IX contains genes with homology to those encoding a two-component regulatory 
system, a carbon starvation protein, and secreted proteins, but it does not contain any 
mobilization genes.
X gbs1118-1153 
(gbs1118-1152*)
36 (35)* Island X appears to be mobile in that it is present in strain NEM316 but not in strain 
2603VR, and it contains transferase, relaxase and some genes homologous with those in 
Tn5252. It also contains 3 LPXTG genes and a DNA methyltransferase. There are no 
known virulence genes.
XI gbs1214-1224 11 Island XI is composed of three genes that are present in both strains NEM316 and 
2603VR, and these are involved in murein hydrolase export. Eight genes in island XI are 
present in strain NEM316, but not in strain 2603VR. One of these is an integrase, and the 
element is adjacent to a tRNA gene. None of the 8 genes appears to have a role in 
virulence.
XII gbs1296-1373 78 Island XII is a good candidate for a pathogenicity island. The virulence genes lmb 
(gbs1307), and scpB (gbs1308), encoding laminin binding protein and C5a peptidase, 
respectively, are at the proximal end of island XII, and are part of a large compound 
transposon. Upstream of lmb/scpB, gbs1296-1306, are five transposon (ISSdy1) or phage 
related genes, and downstream of lmb/scpB, gbs1309-1313 and gbs1338-1340, are other 
transposon (Tn5252) genes. In the distal half of island XII, 24 genes are present in strain 
NEM316 (gbs1314-1337; encoding phage and plasmid replication genes and the lac 
operon) that do not occur in strain 2603VR. In the same relative location in the genome, 
20 genes (sag1253-1272; encoding heavy metal transporters) are present in strain 2603VR 
that do not occur in strain NEM316.Page 4 of 13
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BMC Microbiology 2005, 5:31 http://www.biomedcentral.com/1471-2180/5/31insert between purK and purB. Other inserts between purK
and purB are identifiable in the genome sequences of
other pathogenic streptococci (figure 2), hence fulfilling
the criteria for an MME.
Another disparity between the two GBS whole genome
sequences is the gene gbs0048 (a Cro/CI transcriptional
regulator) in strain NEM316, which has a different proxi-
mal half compared to its homologue sag0048 in strain
2603VR.
The presence of putative pathogenicity islands as defined 
by CGH
The presence of putative pathogenicity islands as
defined by CGH.  Results of PCR (figure 3) and CGH (fig-
ure 4) analyses. The genes and GBS strains shaded grey in
table 2 are those included in CGH experiments, table 3.
Sag0001 encodes dnaA, a positive control for PCR. The
NEM316 strain is a positive control. The pNEM316-1
plasmid is located three times in the NEM316 genome,
and in figure 1 is represented as 'islands III, VII and VIII'.
The strains are divided into three groups: colonizing
strains from healthy pregnant women, and strains causing
early- and late-onset sepsis in babies; and are sub-divided
into those strains for which we have PCR results, and
those for which we have PCR and CGH data.
Some putative PAIs are almost always present in the strain 
collection
Islands II, IV, V, IX and XII-XIV are almost always present
in every strain from our strain collection. An occasional
gene could not be amplified in one or more strains. For
instance, sag1246, located in the distal half of island XII,
could not be amplified in strains J99, B9, MK3, M1, and
J87 (see figure 3). However, sag1233, located in the prox-
imal half of island XII, could be amplified in all strains.
The whole genome comparison of strains NEM316 and
2603VR revealed inter-strain sequence divergence at the
distal end of island XII, whereas the proximal end of
island XII, containing lmb/scpB (sag1234-1235), is highly
conserved between these two strains (see table 1). Ampli-
fication of sag1233 therefore best reflects the presence of
the putative PAI. Sag1233 may be particularly hard to PCR
amplify because sequence divergence affects primer
annealing. Similar sequence divergence between strains
may also explain our inability to amplify occasional genes
in islands V and XIII.
These islands are present in all strains tested, whether iso-
lated from disease or colonizing sites and therefore do not
meet the PAI definition criteria (2) and (5), above: that
they should be present in pathogenic but absent from
non-pathogenic strains, and they should be unstable and
delete with distinct frequencies. Colonizing is not neces-
sarily synonymous with non-pathogenic, a fact that con-
founds interpretation of a genetic comparison of invasive
and colonizing strains.
Some putative PAIs are almost always absent in the strain 
collection
Copies of pNEM316-1, represented by islands III, VII and
VIII, are only found in strain NEM316, and are consist-
ently absent from the other strains in our collection. Five
genes were amplified from island X. They were only all
consistently amplifiable from strain NEM316. Two or
three genes from island X, however, were amplified in 4
strains other than NEM316, reflecting either the part pres-
ence of the island in these strains or marked sequence
divergence. These islands, that are absent from most dis-
ease causing strains, are unlikely to be PAIs. However, the
central part of island X is present in 5 strains known to
have caused early-onset sepsis, and absent from all colo-
nizing and late-onset sepsis strains.
XIII gbs1965-2011 47 Inserted into the proximal end of island XIII, adjacent to tRNA-Lys, are 20 genes in strain 
NEM316 (gbs1965-1984; function mostly unknown, but not obvious virulence genes) that 
is not present in strain 2603VR, and 47 genes in strain 2603VR (sag1979-2025; containing 
several phage genes) that are not present in strain NEM316. The downstream half of the 
island (gbs1987-2011) is identical in strains NEM316 and 2603VR and contains genes 
encoding the CAMP factor, two proteases, core metabolic enzymes, two transporters, 
and a two-component regulator. There are no mobilization genes in this half of the island.
XIV gbs2071-2092 
(gbs2064*-2092)
22 (29)* Inserted into the proximal end of island XIV are 16 genes in strain NEM316 (gbs2064-
2079; containing numerous phage genes) that are not present in strain 2603VR, and 10 
genes in strain 2603VR (sag2111-2120; containing phage genes) that are not present in 
strain NEM316. The remainder of the island contains genes encoding 2 two-component 
regulators, 2 membrane proteins and enzymes involved in metabolism, but no obvious 
virulence or mobilization genes.
* Re-annotation of putative pathogenicity islands based upon the location of mobile DNA present in strain NEM316 but absent from strain 2603VR.
Table 1: The structure of 14 putative PAIs. (Continued)Page 5 of 13
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An example of an MME in GBS. Different intergenic regions are depicted between purK (pale blue block) and purB (laven-
der block) in various streptococcal species. Homologs of gbs0045 are indicated with an asterix. Hypothetical proteins are des-
ignated 'hypo'.Page 6 of 13
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collection
Two genes amplified from each of islands I and VI
revealed a variable presence of these islands in the strains
of our collection (see figure 3). Island I is at least part-
present in 14 of 18 colonizing strains (78%), 8 of 13 early-
onset sepsis strains (61%), and 6 of 8 late-onset sepsis
strains (75%). Although island I meets the PAI criteria of
being variably present in the species, there is no relation-
ship between the whole or part presence of the island and
whether the strain was colonizing or disease causing. The
two genes amplified from island I were sag0224 and
sag0234. Sag0234 is close to the only recognisable viru-
lence gene in island I, rgg (sag0239; homologue of a viru-
lence regulator in S. pyogenes), and thus amplification of
this gene reflects the presence of the most important part
of the island. Sag0234 homologues are present in 13 of 18
colonizing strains (72%), in 7 of 13 early-onset sepsis
strains (53%), and in 6 of 8 late-onset sepsis strains
(75%). Thus, in this relatively small collection, there is no
relationship between the presence of the distal half of
island I and whether the strain was a colonizing or disease
causing isolate.
Island VI is at least part present in all colonizing strains,
12 of 13 early-onset sepsis strains, and all late-onset sepsis
strains. There is therefore no relationship between the
island and disease. The proximal marker gene sag0645 is
closer to the cyl locus (encoding the β-hemolysin, a major
contributor to virulence in GBS) than the distal marker
gene, sag0685, and therefore possibly better reflects the
presence of a PAI that contains Tn5252 transposon genes
and the cyl locus. Sag0645 is present in 14 of 18
colonizing strains (78%), in 9 of 13 early-onset sepsis
strains (69%), and in 7 of 8 late-onset sepsis strains
(87.5%). Although these differences are not statistically
The presence of putative pathogenicity islands as defined by PCRFigure 3
The presence of putative pathogenicity islands as defined by PCR.  Results of PCR (figure 3) and CGH (figure 4) anal-
yses. The genes and GBS strains shaded grey in table 2 are those included in CGH experiments, table 3. Sag0001 encodes 
dnaA, a positive control for PCR. The NEM316 strain is a positive control. The pNEM316-1 plasmid is located three times in 
the NEM316 genome, and in figure 1 is represented as 'islands III, VII and VIII'. The strains are divided into three groups: colo-
nizing strains from healthy pregnant women, and strains causing early- and late-onset sepsis in babies; and are sub-divided into 
those strains for which we have PCR results, and those for which we have PCR and CGH data.Page 7 of 13
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putative PAI in late-onset sepsis strains. A larger study is
required to bear out this finding.
Comparative genomic hybridization analysis
Comparative genomic hybridisation (CGH) analysis was
performed on 22 of the 39 strains assessed by PCR. These
22 strains were randomly selected and included 15 of the
18 colonizing strains, 3 of the 13 isolates that caused
early-onset sepsis, and 4 of the 8 strains that caused late-
onset sepsis.
For probes to the island genes, the results of CGH (figure
4) are near identical to those of PCR (figure 3), with only
a few exceptions. Notable is the hybridization of strains
Z50 and K1 DNA to the gbs0367 gene probe, suggesting
that this gene, and therefore possibly the whole or part of
pNEM316-1, is present in these strains. However, the
presence of pNEM316-1 was not detected by PCR in these
or any other strain except the control NEM316 strain.
Thus, perhaps the gene sequence of pNEM316-1 is diver-
gent in strains Z50 and K1 so that the primers for PCR
were unable to anneal, or that CGH detected a similar
gene to gbs0367. We propose that similar reasons account
for the other few discrepancies that exist between the PCR
and CGH results. In general, however, the CGH and PCR
results are highly consistent.
Although not the main focus of this study, the presence of
the other genes for which probes were included on the
sub-microarray was also assessed by CGH. Eighty five per-
cent of all the 384 probes included on the sub-microarray
The presence of putative pathogenicity islands as defined by CGHFigure 4
The presence of putative pathogenicity islands as defined by CGH.  Results of PCR (figure 3) and CGH (figure 4) 
analyses. The genes and GBS strains shaded grey in table 2 are those included in CGH experiments, table 3. Sag0001 encodes 
dnaA, a positive control for PCR. The NEM316 strain is a positive control. The pNEM316-1 plasmid is located three times in 
the NEM316 genome, and in figure 1 is represented as 'islands III, VII and VIII'. The strains are divided into three groups: colo-
nizing strains from healthy pregnant women, and strains causing early- and late-onset sepsis in babies; and are sub-divided into 
those strains for which we have PCR results, and those for which we have PCR and CGH data.Page 8 of 13
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indicating that at least for the region of the gene chosen
for the probe design there is very little variability between
the strains. However, hybridization to 15% of the probes
was variable in at least three of the 22 strains tested. In
most instances there was no probe hybridization, but
occasionally the hybridization signal was reduced, sug-
gesting sequence variation within the probe region. The
genes with presumed sequence divergence encoded six
sortases, ten proteins with an LPXTG signal sequence, two
clp proteases, one ABC transporter and five PTS proteins,
thirteen putative or known regulators, and sixteen other
proteins (see table 2). Of these, several are genes with pos-
sible virulence enhancing roles (highlighted bold in table
2), including three virulence regulators rgf (sag1956-7)
[16], a putative rofA-like protein (RALP, sag1463) [17]
and rogB (sag1409) [18], two genes in the cyl operon
(sag0662 and sag0664) [19], cfb (sag2043) encoding the
CAMP factor [20], and pavA (sag1190; adherence and vir-
ulence protein A) [21], and are therefore worthy of further
disease association studies. Of note, putative homologues
of the major virulence regulators of Streptococcus pyogenes
[22], such as mga (sag0277), rofA/nra (sag1356, sag1359,
sag1409, and sag1463), and rgg/ropB (sag1490, sag2158),
and all the other identifiable regulators included on the
array (reviewed by Herbert et al [23]) are non-variable in
their hybridization pattern, across the strain collection.
Discussion
By combining the results of genome comparison and
PCR/CGH analysis we can make the following arguments
about the likelihood that each of the putative PAIs is a true
PAI:
Island I may be a true PAI. It contains the virulence regu-
lator rgg, which is flanked by mobilization genes, and the
whole island is variably present in strains of our collec-
tion. It does not appear to be found preferentially in GBS
isolates that are known to have caused disease, but the
number of isolates tested in this study may be too small to
tease out small contributions of a PAI to invasiveness. A
confounding factor is that the colonizing isolates in our
collection may have the capacity to cause disease. Thus,
our colonizing and disease isolates do not simply reflect
non-pathogenic and pathogenic strains, respectively. This
study is not powered to identify small contributions of a
putative PAI to the propensity of serotype III to cause late-
onset sepsis. Only a very large study is likely to do this.
Island II is unlikely to be a true PAI. In strains NEM316
and 2603VR there are two different mobile elements
inserted at the same relative genomic location into the
proximal end of the island, neither of which appears to
harbour virulence genes. This suggests that the proximal
end of island II is a hot spot for the insertion of mobile
elements. Furthermore, the distal half of island II does not
appear to have mobilization machinery and is present in
all the strains within our collection. Islands III, VII and
VIII are near-identical copies of a chromosomally
integrated plasmid, pNEM316, which contains no known
virulence determinants and which is only present in strain
NEM316, and is not present within other strains within
our collection. Thus, this plasmid is unlikely to be a PAI.
Islands IV and V are unlikely to be PAIs for the same rea-
son as island II. Island VI may be a true PAI as it contains
the cyl locus adjacent to Tn5252 (present in both strains
NEM316 and 2603VR), has a mosaic-like structure, and is
variably present in our strain collection. We cannot show
a relationship between the presence of island VI and
strains causing disease, but this may be due to limitations
of the power of this study. Island IX does not contain
mobilization genes and is present in all strains within our
collection, making it unlikely that it is a PAI. Island X is
mobile, but does not contain obvious virulence determi-
nants. The whole of island X is only found in strain
NEM316, and parts of it within four other strains causing
early-onset sepsis. There may thus be an association
between the middle of island X, gbs1125-1135, and the
capacity of an isolate to cause chorioamnionitis. Early-
onset sepsis in a newborn baby reflects invasive disease in
a pregnant mother, whereas the fetus is merely a vulnera-
Table 2: Genes variably present in GBS strains, as defined by CGH analysis
Functional category Gene
Sortases sag0633, sag0647-8, sag0650, sag1406-7
LPXTG proteins sag0433, sag0645-6, sag0649, sag1333, sag1404, sag1407-8, sag1462 and sag2063
clp proteases sag1294 and sag1585
Transporters sag1517, sag1998-90, sag1902 and sag1934
Regulators sag0048, sag0124, sag0169, sag 0637, sag0644, sag1128, sag1332, sag1359, sag1409 (rogB), sag1463 (encoding 
a RALP), sag1791, and sag1956-7 (rgf)
Encoding other proteins sag0031, sag 0624, sag0662 (cyl operon), sag0664 (cyl operon), sag0825, sag1190 (pavA), sag1283, sag1417, 
sag1442, sag1472, sag1510, sag1558, sag1603, sag1675, sag1772, and sag2043 (cfb)
Genes highlighted in bold have a known or likely role in virulence.Page 9 of 13
(page number not for citation purposes)
BMC Microbiology 2005, 5:31 http://www.biomedcentral.com/1471-2180/5/31ble secondary host. The potential association between
island X and early-onset sepsis needs a larger study for
clarification. Island XI is mostly composed of a small
mobile element present in strain NEM316, but not strain
2603VR, and does not contain known virulence genes.
Island XII contains mobilization and virulence genes, has
a mosaic like structure, the distal end of it is variably
present in strains of our collection. It could therefore be a
PAI. Our study does not have the power to identify an
association between the presence of the island and dis-
ease. Islands XIII and XIV are unlikely to be PAIs for the
same reason as island II.
Conclusion
The majority of late-onset meningitis, and to a lesser
extent late-onset sepsis, is caused by serotype III strains.
There is likely to be a bacterial genetic basis for this inva-
sive propensity. A comparison of the whole genome
sequences of a serotype III isolate, NEM316, and a sero-
type V isolate, 2603VR, is remarkable in the degree of sim-
ilarity of the two strains, but there are some
dissimilarities. These include open reading frame annota-
tion discrepancies, genes that show sequence divergence
between strains, an MME, mobile DNA, and the capsula-
tion loci. This study contributes to our understanding of
pathogenesis by further delineating the nature of mobile
elements in GBS. Individual GBS isolates probably carry
their own unique aliquot of horizontally acquired genetic
material. Only four (islands I, VI, X and XII) of 14 putative
PAIs are likely to be real PAIs, but there is no absolute
association of any of these four PAIs with strains causing
disease. The strongest possible disease association is with
island X and early-onset sepsis.
Methods
Strains and culture conditions
GBS isolates were cultured overnight in Todd-Hewitt
broth (Oxoid). DNA was extracted from 39 isolates of
GBS (table 3): 18 colonizing strains; 13 strains derived
from babies with early-onset sepsis (early-onset sepsis);
and 8 strains from babies with late-onset sepsis. The con-
trol strain was NEM316 (CIP82.45, Collection de l'Insti-
tut Pasteur).
Genome comparisons
GBS serotype III strain NEM316 and serotype V strain
2603VR genome sequences were compared through NCBI
[24,25] and using AceDB [11,12], hosted by the
University of Oxford Bioinformatics Centre [26]. Addi-
tional information on domains and homologies were
obtained through NCBI BLAST searches [27] and the
NCBI Conserved Domain Search [28].
Molecular Methods
DNA was extracted from a 3 ml culture of each strain using
spin column technology (DNAeasy; Qiagen), following
the manufacturer's recommendations with the exception
that lysozyme was replaced by mutanolysin (50 units per
extraction) and the cell pellet was pre-incubated with this
enzyme for 60 minutes at 37°C.
Double strand sequencing was conducted by the Depart-
ment of Biochemistry Core Sequencing Facility, Univer-
sity of Oxford, using the same primers employed for the
PCR using gel extracted (Qiagen) templates. Sequencing
reactions used Big Dye version 3 (Applied Biosciences)
and were analyzed on an ABI377 sequencer. Sequences
were assembled, evaluated, and interpreted using Chro-
mas v2.3 (Technelysium Pty Ltd) and ClustalW [29].
PCR analysis
A standard PCR condition, Taq DNA polymerase (Roche)
with 1.5 mM Mg2+, gene-specific primers (table 4) and an
annealing temperature of 56°C, was established for
amplifying one to five genes from each island in the
NEM316 control strain, and the same PCR conditions
were used to attempt amplification in the other 38 strains
in our collection. The presence of a correct size amplicon
was used as a surrogate marker of the presence of the
Table 3: Strains employed for PCR and CGH analysis.
Serotype Colonizing Early-onset sepsis Late-onset sepsis
Ia Z18A, Z81A J99, J67 -
Ib Z69A, Z72A, Z73, Z87A, Z111 J96 -
II Z77A - J87
III Z73, Z34A, Z50, Z101A, Z117 B9, H11, J81, J88, J100, R1, WC3, NEM316 M1, MK2, J76, J95, B11, J90, K1
V Z84A, Z12A, Z87A, Z95 B3 -
NT Z41 MK3 -
The strains are a subset of those used for multilocus sequence typing (MLST) of GBS. Strains indicated in bold were assessed by PCR and CGH. 
Non-highlighted strains were only assessed by PCR. NT = nontypeable; NEM316 = CIP82.45 (Collection de l'Institut Pasteur).Page 10 of 13
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a strain, the PCR was repeated with lower stringency
conditions, by increasing to 2.5 mM Mg2+ and decreasing
the primer annealing temperature to 52°C. For all 39
strains, the gene dnaA (gbs0001, sag0001) was success-
fully PCR amplified, indicating that there were no signifi-
cant PCR inhibitors in our DNA preparations. Consistent
results were achieved with the PCR independently per-
formed twice (by DM and EA). We did not attempt to
amplify a gene from 'island XI' as our genome alignment
and annotation clearly identified that the major part of
this island was a small prophage found in NEM316 but
not 2603VR. For MME amplification, primers were
designed to the 3'-end of purK and the 5'-end of purB.
Comparative genome hybridization
Fifteen gene-specific probes from within the islands were
incorporated into a 384-probe GBS sub-microarray being
developed to study regulatory networks in GBS (unpub-
lished). The other probes were designed from 369 genes
representing all the identifiable regulators (including
homologues of Streptococcus pyogenes regulators such as
rofA, rggB, mga), all the known GBS virulence factors,
stress adaptation molecules, and proteins with LPXTG
sorting signals, and many transporters (focussing on ABC
and PTS systems). Probe regions were chosen using
AceDB [11,12], so that where the gene was present in both
strains, a region of greater than 300 bp region was chosen
that was near identical in each of the sequenced genomes
that was devoid of repetitive elements. Primers were
designed using Primer3 [30], with the product size set at
an optimum of 300 bp (range 150–450 bp), the primer
size at 19 bp (range 17–21), the primer Tm set at 58°C
(range 54–63), the primer GC% at 40 (range 30–80), and
the GC clamp option set to 1. The primers were synthe-
sised commercially (Operon). See Additional file 1 for
sequence information. Amplicons were generated using
DNA extracted from the sequenced serotype III strain
NEM316 [4]. The printed probes were amplified from a
1:50 dilution of these products by second-round PCR
using the first-round primers, once a single band of the
correct size had been obtained from the first reaction, a
similar single band was confirmed from the second round
PCR. PCR products were checked using 96-well E-gels
(Invitrogen). Probes were spotted onto Genetix amine
microarray slides in Genetix amine spotting solution for
Table 4: Primers for PCR
Gene assignment in 
strain NEM316
Gene assignment in 
strain 2603VR
Putative island Primer Pairs
gbs0001 sag0001 - 5'-gtagctgatagtcctggc-3' and 5'-agtccccaactaaagcgc-3'
gbs0045-46 sag0046 MME 5'-aaatgggacacgtacgg-3' and 5'-attgccgccatctcaggg-3'
gbs0217
gbs0227
sag0224
sag0234
I 5'-caagcctttaatgctcgc-3' and 5'-aactgaaattccaatcgcc-3'
5'-tcatcgcgaaaatatggag-3' and 5'-cggtcttttagaaactgtgtcc-3'
gbs0247 sag0254 II 5'-gacttatttcaagtttatgg-3' and 5'-acccttatatacgacagc-3'
gbs0367
gbs0388
gbs0393
- pNEM316-1 
(islands III, VII and VIII)
5'-atcgatttaggattcatgcc-3' and 5'-caacattcgcaaaataagcc-3'
5'-cctagatggcgtagaggcag-3' and 5'-ttgctcacagaccataagcg-3'
5'-tcacccctgagacgtttacc-3' and 5'-gatcgtaaccacggtttgct-3'
gbs0467 sag0430 IV 5'-attgatagatcttacttgcg-3' and 5'-tgatgcaatagctattggc-3'
gbs0589
gbs0598
sag0610
sag0617
V 5'-cagggtgttcaaggctacc-3' and 5'-caagcttacgcacccaag-3'
5'-ctttcctaaaacatatttgg-3' and 5'-atatggtaaaaacttaaggc-3'
gbs0628
gbs0660
sag0645
sag0685
VI 5'-tagctcagtttgcgactgg-3' and 5'-ccaacttttgcatctgctg-3'
5'-aattcttgattgatgagcg-3' and 5'-tcagctttaatcaattccc-3'
- sag0915 Tn916 5'-aagaccaaaagtggcgaac-3' and 5'-gcctttggattcattcctg-3'
gbs1050
gbs1073
sag1015
sag1038
IX 5'-agcagttacttgatttgcc-3' and 5'-tcctgaattagctagtcgc-3'
5'-tctgcttgagataactccc-3' and 5'-caatagcagttatcaaaggg-3'
gbs1120
gbs1125
gbs1135
gbs1143
gbs1145
- X 5'-cctagatggcgtagaggcag-3' and 5'-ttgctcacagaccataagc-3'
5'-tcgacgtgttttacggttg-3' and 5'-accgaagagatgatgacgac-3'
5'-gggccacactagaaactgc-3' and 5'-aaatccttcatcgctcctg-3'
5'-tcacccctgagacgttacc-3' and 5'-gatcgtaaccacggtttgct-3'
5'-tctctcggcgttattgtcc-3' and 5'-acaaaagcacaagcgactg-3'
gbs1306
gbs1313
sag1233
sag1246
XII 5'-ctttactggcttcacttgg-3' and 5'-gttgatacaggcattgagc-3'
5'-gattactctaccagtgagg-3' and 5'-agaatagtctgcttcaccc-3'
gbs1987
gbs2008
sag2029
sag2053
XIII 5'-ctgacaattgctttgtttcg-3' and 5'-ggctaacccaaatgtaccg-3'
5'-gctcctctgattaatgccc-3' and 5'-caagctcttgttcggttgc-3'
gbs2082 sag2123 XIV 5'-tttctgggaaaaatcagtgg-3' and 5'-ttttcccgaacaaatgatg-3'Page 11 of 13
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(Genetix) using 150 micron tipped solid tungsten pins
(Genetix). FluoroLink™ Cy3-dCTP and FluoroLink™ Cy5-
dCTP (Amersham Pharmacia Biotech) were incorporated
into 10 µg of chromosomal DNA using random hexamer
primers (Invitrogen) and DNA polymerase I, Klenow frag-
ment (Bioline, UK). Labelled DNA:DNA probe microar-
ray hybridizations were conducted in 4x SSC, 0.2875%
SDS at 65°C overnight.
Of the 384 gene-specific probes included on the array,
seven probes were directed at serotype-specific capsular
polysaccharide synthesis genes and were thus
hybridization controls. Another five probes were directed
at genes in pNEM316-1 and 'island X' that only infre-
quently hybridized to the DNA from the strains in the
collection.
The probes were chosen in gene regions that were of low
complexity, contained no repeats, and were identical
according to our alignment of the NEM316 and 2603VR
genomes using AceDB.
Identification of strain differences within the non-island
genes was not the initial purpose of this study. However,
such variation, in the context of the relative paucity of dif-
ferences found in islands genes, indicates that allelic vari-
ants of the non-island genes may explain differences in
strain behaviour. A larger scale project directed at these
genes, using a microarray based upon a greater number of
genome sequences than were available for this project, is
needed to specifically investigate this type of divergence.
Probes to genes from each of islands I-XIV were included
on the array, with the exception of 'islands IX and XI'. PCR
analysis demonstrated that the 'island IX' region is con-
sistently present in all strains in our collection, and our
analysis did not support the notion that it contains
mobile DNA. The major part of 'Island XI' is a small
prophage, and we therefore expected it not to be relevant
to the virulence of the organism. One probe was included
to each 'island', except for two probes to 'islands I and V',
and five probes to 'island X'.
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